金斯瑞生物科技跌超4% 联营传奇生物三季度净亏损收窄至3970万美元

Core Viewpoint - Kingsray Biotechnology (01548) experienced a decline of over 4%, trading at HKD 16.43 with a transaction volume of HKD 221 million as of the report date [1] Financial Performance - Legend Biotech, a joint venture of Kingsray Biotechnology, reported a net loss of USD 39.7 million for the three months ending September 30, 2025, compared to a net loss of USD 125.3 million in the same period last year [1] - The adjusted net loss for the same period was USD 18.8 million, down from an adjusted net loss of USD 42 million year-over-year [1]